<DOC>
	<DOCNO>NCT03106519</DOCNO>
	<brief_summary>Treatment Dupuytren 's contracture require multiple injection palm hand weaken cord , follow rupture strand 2 day later . Anesthesia required phase treatment . It hypothesize extended-release liposome bupivacaine prolongs nerve blockade wrist allow patient undergo 2-part regimen less pain .</brief_summary>
	<brief_title>Liposome Bupivacaine WRIST Blocks</brief_title>
	<detailed_description />
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Dupuytren Contracture</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Male female , least 18 year max 85 year age screen Scheduled undergo Dupuytren 's contracture release American Society Anesthesiologists ( ASA ) physical status I , II III Able demonstrate sensory function exhibit sensitivity cold , pinprick light touch Female subject must surgically sterile monogamous partner surgically sterile ; least 2 year postmenopausal ; practice abstinence ; use insertable , injectable , transdermal , combination oral contraceptive approve FDA great 2 month prior screen commit use acceptable form birth control duration study 30 day completion study Able understand English Dutch language , purpose risk study Able provide inform consent authorization use protect health information , adhere study visit schedule complete study assessment Currently pregnant , nurse plan become pregnant study within 1 moth study drug administration History hypersensitivity local anesthetic Contraindication bupivacaine , paracetamol , ketorolac , oxycodone morphine Medical condition make difficult assess sensory distribution peripheral nerve communicate staff Chronic schedule use follow medication within time specify surgery : longacting opioid medication NSAIDs ( except lowdose aspirin use cardioprotection ) within 3 day , opioid medication within 24 hour Suspected known recent history ( &lt; 3 month ) drug alcohol abuse Concurrent physical condition may require analgesic treatment ( NSAID opioid ) postsurgical period pain strictly relate Dupuytren 's contracture may confound postsurgical assessment Infection plan block site Initiation treatment follow medication within 1 month study drug administration medication ( ) give control pain : selective serotonin reuptake inhibitor ( SSRIs ) , selective norepinephrine reuptake inhibitor ( SNRIs ) , gabapentin , pregabalin ( Lyrica® ) , duloxetine ( Cymbalta® ) Use dexmedetomidine HCl ( Precedex® ) within 3 day study drug administration Body weight &lt; 40 kg ( 88 pound ) body mass index &gt; 44 kg/m2 Uncontrolled anxiety , psychiatric , neurological disorder might interfere study assessment Any chronic neuromuscular deficit affect peripheral nerve muscle surgical extremity Any chronic condition disease would compromise neurological vascular assessment Presence preexist coagulation disorder Baseline neurological deficit History impair kidney function , chronic respiratory disease , rheumatoid arthritis , coagulopathy loss sensation extremity Impaired kidney function ( e.g. , serum creatinine level &gt; 2 mg/dL [ 176.8 µmol/L ] blood urea nitrogen level &gt; 50 mg/dL [ 17.9 mmol/L ] ) impair liver function ( e.g. , serum aspartate aminotransferase [ AST ] level &gt; 3 time upper limit normal ( ULN ) serum alanine aminotransferase [ ALT ] level &gt; 3 time ULN Previous participation EXPAREL study Administration investigational drug within 30 day 5 elimination halflives investigational drug , whichever longer , prior study drug administration , plan administration another investigational product procedure subject 's participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>